FindTrial
Sign In

Gout and hyperuricemia clinical cohort

Clinical cohort project——gout and hyperuricemia (reserve)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500110993
Enrollment
Unknown
Registered
2025-10-23
Start date
2025-07-22
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gout and Hyperuricemia

Interventions

Gout group:no
Hyperuricemia group :no

Sponsors

Huashan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Met the 2015 American College of Rheumatology (ACR) and European League Against Rheumatism (EULAR) diagnostic criteria for gout; 2. Met the diagnostic criteria of hyperuricemia, that is, under the condition of normal purine diet, adults, both men and women, have fasting blood uric acid levels higher than 420 µ mol/l twice a day; 3. Unlimited age and gender; 4. The study participants were informed and voluntarily signed the informed consent form, and agreed to follow-up according to the requirements of cohort data collection and accept relevant examinations;

Exclusion criteria

Exclusion criteria: 1.Pregnant, pregnant or lactating women; 2.Mental disease, no insight, unable to express exactly; 3.Those who refuse to sign informed consent;

Design outcomes

Primary

MeasureTime frame
ucic acid;—

Countries

China

Contacts

Public ContactZhu Xiaoxia

Huashan Hospital, Fudan University

15901811889@163.com+86 21 52887332

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026